Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

127.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 139.50p
  • 52 Week Low: 96.00p
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 75,554
  • Market Cap: £133.06m
  • RiskGrade: 95

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
23.42% above the market average23.42% above the market average23.42% above the market average23.42% above the market average23.42% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average
1yr Revenue Growth
55.47% below the market average55.47% below the market average55.47% below the market average55.47% below the market average55.47% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
11.85% below the market average11.85% below the market average11.85% below the market average11.85% below the market average11.85% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
1yr DPS Growth
5.21% above the market average5.21% above the market average5.21% above the market average5.21% above the market average5.21% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
56.8% below the market average56.8% below the market average56.8% below the market average56.8% below the market average56.8% below the market average
92.31% below the sector average92.31% below the sector average92.31% below the sector average92.31% below the sector average92.31% below the sector average
Price Book Ratio
22.5% below the market average22.5% below the market average22.5% below the market average22.5% below the market average22.5% below the market average
43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
0.66% above the market average0.66% above the market average0.66% above the market average0.66% above the market average0.66% above the market average
Sector averageSector averageSector averageSector averageSector average
Price Chg 3m
3.70% above the market average3.70% above the market average3.70% above the market average3.70% above the market average3.70% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
0.64% below the market average0.64% below the market average0.64% below the market average0.64% below the market average0.64% below the market average
2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average
Momentum 20
9.2% below the market average9.2% below the market average9.2% below the market average9.2% below the market average9.2% below the market average
12.82% below the sector average12.82% below the sector average12.82% below the sector average12.82% below the sector average12.82% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
16.86% below the market average16.86% below the market average16.86% below the market average16.86% below the market average16.86% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
ROCE
72.86% above the market average72.86% above the market average72.86% above the market average72.86% above the market average72.86% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
21.10% above the market average21.10% above the market average21.10% above the market average21.10% above the market average21.10% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Forecast EPS
42.47% below the market average42.47% below the market average42.47% below the market average42.47% below the market average42.47% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.51% above the market average43.51% above the market average43.51% above the market average43.51% above the market average43.51% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
24.05% above the market average24.05% above the market average24.05% above the market average24.05% above the market average24.05% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
30.17% above the market average30.17% above the market average30.17% above the market average30.17% above the market average30.17% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Cash
6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
16.14% above the market average16.14% above the market average16.14% above the market average16.14% above the market average16.14% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Buys 1y
27.32% above the market average27.32% above the market average27.32% above the market average27.32% above the market average27.32% above the market average
44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
27.41% above the market average27.41% above the market average27.41% above the market average27.41% above the market average27.41% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today 0.50p
% Change 0.40 %
52 Week High 139.50p
52 Week Low 96.00p
Volume 75,554
Shares Issued 104.77m
Market Cap £133.06m
RiskGrade 95

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average
Income
10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 20-Sep-2019

Time Volume / Share Price
17:07 3,000 @ 127.00p
16:00 6,300 @ 126.50p
15:58 3,000 @ 127.28p
15:54 3,939 @ 126.92p
15:33 3,500 @ 126.92p

Cello Health Key Personnel

CEO Mark Scott

Top of Page